Publication

Licensed Pharmacists Permitted to Administer COVID-19 Tests

Apr 10, 2020

By Vinnie Lichvar

Experts have repeatedly emphasized the importance of increased testing for COVID-19 in an effort to maintain some control over this pandemic. With this goal in mind, on April 8, 2020, the Office of the Assistant Secretary for Health (“OASH”) took a step to meet current testing demands by issuing guidance for licensed pharmacists regarding their ability to assist with COVID-19 testing.1 Specifically, OASH authorized licensed pharmacists to order and administer COVID-19 tests, which include serology tests, that the Food and Drug Administration has authorized.

Importantly, OASH directed that pharmacists qualify as “covered persons” under the Public Readiness and Emergency Preparedness Act (“PREP Act). The PREP Act authorizes the Secretary of the Department of Health and Human Services (“HHS”) to issue a PREP Act declaration, which provides immunity from liability for any loss caused, arising out of, relating to or resulting from the administration or use of countermeasures to diseases, threats and conditions determined in the Declaration to constitute a present or credible risk of a future public health emergency. The Secretary of HHS issued such a declaration for the COVID-19 pandemic under the PREP Act on March 10, 2020.2

Therefore, pharmacists ordering and administering COVID-19 tests pursuant to OASH’s guidance will receive immunity under this Act.  This means that courts must dismiss claims brought against pharmacists for any loss that relates to any stage of design, development, testing, manufacture, labeling, distribution, formulation, labeling, packing, marketing, promotion, sale, purchase, donation, dispensing, prescribing, administration, licensing or use of these tests. This immunity does not cover willful misconduct by pharmacists.

HHS’s declaration and guidance should assist in increasing the United States’ capacity to perform testing. In fact, several pharmacies, including Walgreens, CVS Health and Target, have already indicated that they will offer drive-thru testing sites.

Footnotes

  1. https://www.hhs.gov/sites/default/files/authorizing-licensed-pharmacists-to-order-and-administer-covid-19-tests.pdf

  2. https://www.federalregister.gov/documents/2020/03/17/2020-05484/declaration-under-the-public-readiness-and-emergency-preparedness-act-for-medical-countermeasures

Back to top

About Snell & Wilmer

Founded in 1938, Snell & Wilmer is a full-service business law firm with more than 500 attorneys practicing in 16 locations throughout the United States and in Mexico, including Los Angeles, Orange County and San Diego, California; Phoenix and Tucson, Arizona; Denver, Colorado; Washington, D.C.; Boise, Idaho; Las Vegas and Reno, Nevada; Albuquerque, New Mexico; Portland, Oregon; Dallas, Texas; Salt Lake City, Utah; Seattle, Washington; and Los Cabos, Mexico. The firm represents clients ranging from large, publicly traded corporations to small businesses, individuals and entrepreneurs. For more information, visit swlaw.com.

©2025 Snell & Wilmer L.L.P. All rights reserved. The purpose of this publication is to provide readers with information on current topics of general interest and nothing herein shall be construed to create, offer, or memorialize the existence of an attorney-client relationship. The content should not be considered legal advice or opinion, because it may not apply to the specific facts of a particular matter. As guidance in areas is constantly changing and evolving, you should consider checking for updated guidance, or consult with legal counsel, before making any decisions.
Media Contact

Olivia Nguyen-Quang

Associate Director of Communications
media@swlaw.com 714.427.7490